CRISPR-Cas9 claim sets and the potential to stifle innovation.
Nature biotechnology, 35(7): 630-633 PMID 28700549 DOI 10.1038/nbt.3913
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.